Weight-Loss Jab Shows Promise in Cancer Prevention and Mental Health Treatment

Weight-loss drug Semaglutide shows promise in treating severe mental illness and preventing cancer, according to a new study. Dr. Zoe, a medical expert on This Morning, discussed the research, highlighting a 50% reduction in obesity-related cancer risk among 6400 patients. "It's really exciting," she commented, "but we need further studies." The research also suggests potential benefits in treating various conditions, including addictions and Alzheimer's. The study's findings underscore the need for continued research into Semaglutide's potential as a treatment for mental illness and cancer prevention.